Exploring the mechanisms through which exercise influences beta cell health in Type 1 diabetes

M. C. Curran, J. C. Campbell, M. D. Drayson, M. G. Gleeson, P. N. Narendran

Research output: Contribution to journalMeeting abstract

Abstract

Aims: Exercise increases beta cell health in people at risk of and with established Type 2 diabetes. These benefits of exercise have not been characterised in Type 1 diabetes. Over 10% of beta cells are still present at the time of diagnosis with Type 1 diabetes, and exercise has the potential to preserve them. We aimed to explore the mechanisms through which exercise could improve beta cell health in Type 1 diabetes by investigating the effects of exercise serum on apoptosis and proliferation of the MIN6 mouse insulinoma cell line. Methods: Fasted blood was taken from 10 healthy male subjects before and after 40 min of varied unsupervised moderate intensity exercise, and from 11 well-trained male subjects before and after a 9 day intensive cycling exercise training study. Apoptosis was measured in MIN6 (24 h + 100 μM H2O2) by flow cytometry (AnnexinV-FITC, 7-AAD staining). Proliferation of MIN6 was measured using Promega CellTiter 96 Aqueous One Cell proliferation assay daily over 4 days. Experimental cultures were supplemented with 10% of either pre- or post-exercise serum. Results: MIN6 incubated in post-exercise serum showed 6.2% (SD ± pre, 12.88; post, 7.39) reduced apoptosis (p = 0.03) and 9% (SD ± pre, 0.339; post, 0.237) increased proliferation (p = 0.002) compared to those incubated in pre-exercise serum, and further increased proliferation by 43% (SD ± pre, 0.256; post, 0.367) with serum following 9 days' intensive training (p <0.001). Summary: Our results suggest exercise protects beta cells from apoptosis and increases their proliferation. Further benefits of exercise on beta cell health and the mechanisms through which they manifest in Type 1 diabetes need characterisation. This provides a basis to explore exercise as a potential therapy for patients with Type 1 diabetes.
LanguageEnglish
Pages76
Number of pages1
JournalDiabetic Medicine
Volume33
Issue numberSuppl. 1
DOIs
StatusPublished - 1 Mar 2016

Fingerprint

Type 1 Diabetes Mellitus
Exercise
Health
Apoptosis
Serum
Insulinoma
Fluorescein-5-isothiocyanate
Type 2 Diabetes Mellitus
Healthy Volunteers
Flow Cytometry
Cell Proliferation

Keywords

  • fish oil
  • hydrogen peroxide
  • fluorescein isothiocyanate
  • health
  • insulin dependent diabetes mellitus
  • diabetes mellitus
  • United Kingdom
  • exercise
  • human
  • serum
  • apoptosis
  • male
  • cell proliferation assay
  • therapy
  • staining
  • flow cytometry
  • mouse
  • diagnosis
  • blood
  • insulinoma cell line
  • non insulin dependent diabetes mellitus
  • patient
  • risk

Cite this

Exploring the mechanisms through which exercise influences beta cell health in Type 1 diabetes. / Curran, M. C.; Campbell, J. C.; Drayson, M. D.; Gleeson, M. G.; Narendran, P. N.

In: Diabetic Medicine, Vol. 33, No. Suppl. 1, 01.03.2016, p. 76.

Research output: Contribution to journalMeeting abstract

Curran, M. C. ; Campbell, J. C. ; Drayson, M. D. ; Gleeson, M. G. ; Narendran, P. N. / Exploring the mechanisms through which exercise influences beta cell health in Type 1 diabetes. In: Diabetic Medicine. 2016 ; Vol. 33, No. Suppl. 1. pp. 76.
@article{abd045a804f74121b5a5e532f03248ad,
title = "Exploring the mechanisms through which exercise influences beta cell health in Type 1 diabetes",
abstract = "Aims: Exercise increases beta cell health in people at risk of and with established Type 2 diabetes. These benefits of exercise have not been characterised in Type 1 diabetes. Over 10{\%} of beta cells are still present at the time of diagnosis with Type 1 diabetes, and exercise has the potential to preserve them. We aimed to explore the mechanisms through which exercise could improve beta cell health in Type 1 diabetes by investigating the effects of exercise serum on apoptosis and proliferation of the MIN6 mouse insulinoma cell line. Methods: Fasted blood was taken from 10 healthy male subjects before and after 40 min of varied unsupervised moderate intensity exercise, and from 11 well-trained male subjects before and after a 9 day intensive cycling exercise training study. Apoptosis was measured in MIN6 (24 h + 100 μM H2O2) by flow cytometry (AnnexinV-FITC, 7-AAD staining). Proliferation of MIN6 was measured using Promega CellTiter 96 Aqueous One Cell proliferation assay daily over 4 days. Experimental cultures were supplemented with 10{\%} of either pre- or post-exercise serum. Results: MIN6 incubated in post-exercise serum showed 6.2{\%} (SD ± pre, 12.88; post, 7.39) reduced apoptosis (p = 0.03) and 9{\%} (SD ± pre, 0.339; post, 0.237) increased proliferation (p = 0.002) compared to those incubated in pre-exercise serum, and further increased proliferation by 43{\%} (SD ± pre, 0.256; post, 0.367) with serum following 9 days' intensive training (p <0.001). Summary: Our results suggest exercise protects beta cells from apoptosis and increases their proliferation. Further benefits of exercise on beta cell health and the mechanisms through which they manifest in Type 1 diabetes need characterisation. This provides a basis to explore exercise as a potential therapy for patients with Type 1 diabetes.",
keywords = "fish oil, hydrogen peroxide, fluorescein isothiocyanate, health, insulin dependent diabetes mellitus, diabetes mellitus, United Kingdom, exercise, human, serum, apoptosis, male, cell proliferation assay, therapy, staining, flow cytometry, mouse, diagnosis, blood, insulinoma cell line, non insulin dependent diabetes mellitus, patient, risk",
author = "Curran, {M. C.} and Campbell, {J. C.} and Drayson, {M. D.} and Gleeson, {M. G.} and Narendran, {P. N.}",
year = "2016",
month = "3",
day = "1",
doi = "10.1111/dme.20_13048",
language = "English",
volume = "33",
pages = "76",
journal = "Diabetic Medicine",
issn = "0742-3071",
publisher = "Wiley-Blackwell",
number = "Suppl. 1",

}

TY - JOUR

T1 - Exploring the mechanisms through which exercise influences beta cell health in Type 1 diabetes

AU - Curran, M. C.

AU - Campbell, J. C.

AU - Drayson, M. D.

AU - Gleeson, M. G.

AU - Narendran, P. N.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Aims: Exercise increases beta cell health in people at risk of and with established Type 2 diabetes. These benefits of exercise have not been characterised in Type 1 diabetes. Over 10% of beta cells are still present at the time of diagnosis with Type 1 diabetes, and exercise has the potential to preserve them. We aimed to explore the mechanisms through which exercise could improve beta cell health in Type 1 diabetes by investigating the effects of exercise serum on apoptosis and proliferation of the MIN6 mouse insulinoma cell line. Methods: Fasted blood was taken from 10 healthy male subjects before and after 40 min of varied unsupervised moderate intensity exercise, and from 11 well-trained male subjects before and after a 9 day intensive cycling exercise training study. Apoptosis was measured in MIN6 (24 h + 100 μM H2O2) by flow cytometry (AnnexinV-FITC, 7-AAD staining). Proliferation of MIN6 was measured using Promega CellTiter 96 Aqueous One Cell proliferation assay daily over 4 days. Experimental cultures were supplemented with 10% of either pre- or post-exercise serum. Results: MIN6 incubated in post-exercise serum showed 6.2% (SD ± pre, 12.88; post, 7.39) reduced apoptosis (p = 0.03) and 9% (SD ± pre, 0.339; post, 0.237) increased proliferation (p = 0.002) compared to those incubated in pre-exercise serum, and further increased proliferation by 43% (SD ± pre, 0.256; post, 0.367) with serum following 9 days' intensive training (p <0.001). Summary: Our results suggest exercise protects beta cells from apoptosis and increases their proliferation. Further benefits of exercise on beta cell health and the mechanisms through which they manifest in Type 1 diabetes need characterisation. This provides a basis to explore exercise as a potential therapy for patients with Type 1 diabetes.

AB - Aims: Exercise increases beta cell health in people at risk of and with established Type 2 diabetes. These benefits of exercise have not been characterised in Type 1 diabetes. Over 10% of beta cells are still present at the time of diagnosis with Type 1 diabetes, and exercise has the potential to preserve them. We aimed to explore the mechanisms through which exercise could improve beta cell health in Type 1 diabetes by investigating the effects of exercise serum on apoptosis and proliferation of the MIN6 mouse insulinoma cell line. Methods: Fasted blood was taken from 10 healthy male subjects before and after 40 min of varied unsupervised moderate intensity exercise, and from 11 well-trained male subjects before and after a 9 day intensive cycling exercise training study. Apoptosis was measured in MIN6 (24 h + 100 μM H2O2) by flow cytometry (AnnexinV-FITC, 7-AAD staining). Proliferation of MIN6 was measured using Promega CellTiter 96 Aqueous One Cell proliferation assay daily over 4 days. Experimental cultures were supplemented with 10% of either pre- or post-exercise serum. Results: MIN6 incubated in post-exercise serum showed 6.2% (SD ± pre, 12.88; post, 7.39) reduced apoptosis (p = 0.03) and 9% (SD ± pre, 0.339; post, 0.237) increased proliferation (p = 0.002) compared to those incubated in pre-exercise serum, and further increased proliferation by 43% (SD ± pre, 0.256; post, 0.367) with serum following 9 days' intensive training (p <0.001). Summary: Our results suggest exercise protects beta cells from apoptosis and increases their proliferation. Further benefits of exercise on beta cell health and the mechanisms through which they manifest in Type 1 diabetes need characterisation. This provides a basis to explore exercise as a potential therapy for patients with Type 1 diabetes.

KW - fish oil

KW - hydrogen peroxide

KW - fluorescein isothiocyanate

KW - health

KW - insulin dependent diabetes mellitus

KW - diabetes mellitus

KW - United Kingdom

KW - exercise

KW - human

KW - serum

KW - apoptosis

KW - male

KW - cell proliferation assay

KW - therapy

KW - staining

KW - flow cytometry

KW - mouse

KW - diagnosis

KW - blood

KW - insulinoma cell line

KW - non insulin dependent diabetes mellitus

KW - patient

KW - risk

UR - http://dx.doi.org/10.1111/dme.20_13048

U2 - 10.1111/dme.20_13048

DO - 10.1111/dme.20_13048

M3 - Meeting abstract

VL - 33

SP - 76

JO - Diabetic Medicine

T2 - Diabetic Medicine

JF - Diabetic Medicine

SN - 0742-3071

IS - Suppl. 1

ER -